Influence of a High-Fat Meal on the Bioavailability of a Two Different Formulations of Risedronate.

Trial Profile

Influence of a High-Fat Meal on the Bioavailability of a Two Different Formulations of Risedronate.

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Oct 2011

At a glance

  • Drugs Risedronic acid (Primary)
  • Indications Postmenopausal osteoporosis
  • Focus Pharmacokinetics
  • Sponsors Procter & Gamble
  • Most Recent Events

    • 19 May 2010 Warner Chilcott Company added as trial sponsor and affiliate in place of Procter and Gamble as reported by ClinicalTrials.gov.
    • 15 Dec 2008 Planned number of patients (76) added as reported by ClinicalTrials.gov.
    • 07 Oct 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top